193 related articles for article (PubMed ID: 32812024)
1. Targeting DNA Methylation Depletes Uterine Leiomyoma Stem Cell-enriched Population by Stimulating Their Differentiation.
Liu S; Yin P; Xu J; Dotts AJ; Kujawa SA; Coon V JS; Zhao H; Shilatifard A; Dai Y; Bulun SE
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32812024
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor-DNA methylation crosstalk regulates depletion of uterine leiomyoma stem cells: A potential therapeutic target.
Liu S; Yin P; Xu J; Dotts AJ; Kujawa SA; Coon V JS; Zhao H; Dai Y; Bulun SE
Stem Cell Reports; 2021 Sep; 16(9):2099-2106. PubMed ID: 34388365
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma.
Liu S; Yin P; Kujawa SA; Coon JS; Okeigwe I; Bulun SE
Oncogene; 2019 Apr; 38(15):2722-2735. PubMed ID: 30538295
[TBL] [Abstract][Full Text] [Related]
4. Activation of protein kinase B by WNT4 as a regulator of uterine leiomyoma stem cell function.
Liu S; Yin P; Dotts AJ; Kujawa SA; Coon V JS; Wei JJ; Chakravarti D; Bulun SE
Fertil Steril; 2020 Dec; 114(6):1339-1349. PubMed ID: 32892998
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of the DNA methylome and transcriptome in uterine leiomyoma shows altered regulation of genes involved in metabolism, proliferation, extracellular matrix, and vesicles.
Carbajo-García MC; Corachán A; Juárez-Barber E; Monleón J; Payá V; Trelis A; Quiñonero A; Pellicer A; Ferrero H
J Pathol; 2022 Aug; 257(5):663-673. PubMed ID: 35472162
[TBL] [Abstract][Full Text] [Related]
6. Human uterine leiomyoma stem/progenitor cells expressing CD34 and CD49b initiate tumors in vivo.
Yin P; Ono M; Moravek MB; Coon JS; Navarro A; Monsivais D; Dyson MT; Druschitz SA; Malpani SS; Serna VA; Qiang W; Chakravarti D; Kim JJ; Bulun SE
J Clin Endocrinol Metab; 2015 Apr; 100(4):E601-6. PubMed ID: 25658015
[TBL] [Abstract][Full Text] [Related]
7. Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.
Koohestani F; Qiang W; MacNeill AL; Druschitz SA; Serna VA; Adur M; Kurita T; Nowak RA
Hum Reprod; 2016 Jul; 31(7):1540-51. PubMed ID: 27130615
[TBL] [Abstract][Full Text] [Related]
8. 5-aza-2'-deoxycitidine inhibits cell proliferation, extracellular matrix formation and Wnt/β-catenin pathway in human uterine leiomyomas.
Carbajo-García MC; Corachán A; Segura-Benitez M; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
Reprod Biol Endocrinol; 2021 Jul; 19(1):106. PubMed ID: 34233687
[TBL] [Abstract][Full Text] [Related]
9. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C
J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352
[TBL] [Abstract][Full Text] [Related]
10. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.
Ono M; Yin P; Navarro A; Moravek MB; Coon JS; Druschitz SA; Serna VA; Qiang W; Brooks DC; Malpani SS; Ma J; Ercan CM; Mittal N; Monsivais D; Dyson MT; Yemelyanov A; Maruyama T; Chakravarti D; Kim JJ; Kurita T; Gottardi CJ; Bulun SE
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17053-8. PubMed ID: 24082114
[TBL] [Abstract][Full Text] [Related]
11. Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma.
Maekawa R; Yagi S; Ohgane J; Yamagata Y; Asada H; Tamura I; Sugino N; Shiota K
J Reprod Dev; 2011 Oct; 57(5):604-12. PubMed ID: 21685710
[TBL] [Abstract][Full Text] [Related]
12. Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.
Wu X; Serna VA; Thomas J; Qiang W; Blumenfeld ML; Kurita T
Cancer Res; 2017 Dec; 77(24):6891-6901. PubMed ID: 29055020
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
14. HMGA2-mediated tumorigenesis through angiogenesis in leiomyoma.
Li Y; Qiang W; Griffin BB; Gao T; Chakravarti D; Bulun S; Kim JJ; Wei JJ
Fertil Steril; 2020 Nov; 114(5):1085-1096. PubMed ID: 32868105
[TBL] [Abstract][Full Text] [Related]
15. Role of stem cells in human uterine leiomyoma growth.
Ono M; Qiang W; Serna VA; Yin P; Coon JS; Navarro A; Monsivais D; Kakinuma T; Dyson M; Druschitz S; Unno K; Kurita T; Bulun SE
PLoS One; 2012; 7(5):e36935. PubMed ID: 22570742
[TBL] [Abstract][Full Text] [Related]
16. Targeting Ovarian Cancer Stem Cells by Dual Inhibition of HOTAIR and DNA Methylation.
Wang W; Fang F; Ozes A; Nephew KP
Mol Cancer Ther; 2021 Jun; 20(6):1092-1101. PubMed ID: 33785648
[TBL] [Abstract][Full Text] [Related]
17. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
Sant'Anna GDS; Brum IS; Branchini G; Pizzolato LS; Capp E; Corleta HVE
Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
[TBL] [Abstract][Full Text] [Related]
18. Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation.
Asada H; Yamagata Y; Taketani T; Matsuoka A; Tamura H; Hattori N; Ohgane J; Hattori N; Shiota K; Sugino N
Mol Hum Reprod; 2008 Sep; 14(9):539-45. PubMed ID: 18701604
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of flavopiridol on human uterine leiomyoma in vitro and in a xenograft model.
Lee HG; Baek JW; Shin SJ; Kwon SH; Cha SD; Park WJ; Chung R; Choi ES; Lee GH; Cho CH
Reprod Sci; 2014 Sep; 21(9):1153-60. PubMed ID: 24572052
[TBL] [Abstract][Full Text] [Related]
20. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]